Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 30.17% | 26.72% | 42.17% | -28.74% | -33.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.72% | 36.77% | 61.06% | 72.70% | 74.56% |
| Operating Income | -29.72% | -36.77% | -61.06% | -72.70% | -74.56% |
| Income Before Tax | -2.10% | -71.09% | -106.49% | -68.09% | -70.30% |
| Income Tax Expenses | 122.89% | 144.21% | 153.15% | 96.33% | 61.75% |
| Earnings from Continuing Operations | -2.73% | -71.82% | -107.37% | -73.15% | -73.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73% | -71.82% | -107.37% | -73.15% | -73.31% |
| EBIT | -29.72% | -36.77% | -61.06% | -72.70% | -74.56% |
| EBITDA | -29.75% | -36.87% | -61.83% | -73.21% | -74.70% |
| EPS Basic | 16.36% | -37.00% | -65.63% | -30.37% | -23.37% |
| Normalized Basic EPS | -3.42% | -5.83% | -27.22% | -32.67% | -27.48% |
| EPS Diluted | 16.36% | -37.00% | -65.63% | -30.37% | -23.37% |
| Normalized Diluted EPS | -3.42% | -5.83% | -27.22% | -32.67% | -27.48% |
| Average Basic Shares Outstanding | 25.86% | 29.20% | 28.13% | 29.47% | 34.30% |
| Average Diluted Shares Outstanding | 25.86% | 29.20% | 28.13% | 29.47% | 34.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |